Tenderwize
Wróć do wyszukiwania

Open House Discount Agreements Amifampridin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 309 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Amifampridin, ATC N07XX05

40/100

Ocena szansy

PromisingLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

20 / 100

Czynniki ryzyka

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Strong opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Enter into non-exclusive discount agreements for the pharmaceutical active substance Amifampridin (ATC N07XX05) with AOK Bayern.
  • Agreements are based on a standardized, non-negotiable contract template.
Pokaż pełne podsumowanie

This notice describes an open house model (not a competitive procurement) for non-exclusive pharmaceutical discount agreements on the active substance Amifampridin (ATC N07XX05) by AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract term. The agreement period is from 01.09.2025 to 31.08.2027, with contracts possible until 03.07.2027. There is no selection process; all qualifying companies that submit the required documents will be accepted. No estimated value is provided. The tender is open only to pharmaceutical companies, and all documents must be in German.

Ryzyka

No guaranteed value; actual revenue depends on market uptake and may be low.

Submission process is specific: use communication area (not offer area) and strictly follow format (electronic qualifie...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Proof of authorization (commercial register extract or power of attorney) for signatories.

Eligibility

  • Only pharmaceutical companies are eligible to participate.

Administrative

  • Submission of a completed and signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria - open house model; any qualified company may join.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreements Amifampridin

Open house model for discount agreements on Amifampridin (ATC N07XX05). Any qualifying pharmaceutical company may join. Contracts start on the first of the month following submission (if submitted by the 3rd). No competitive selection; all eligible participants are accepted. Contract duration 01.09.2025-31.08.2027.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Aug 2025 - Aug 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria - open house model; any qualified company may join.

Termin

Deadline Jul 03, 2027

Szczegóły zamówienia

Data publikacji
13 Jul 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
456857-2025

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30